TABLE 2.
2013 | 2014 | 2015 | 2016 | P for trend | |
Renal parenchymal disease [n (%)] | 42 812 (58.89) | 60 106 (59.58) | 62 841 (56.77) | 62 129 (52.59) | <0.001 |
Renal vascular disease [n (%)] | 2053 (2.82) | 2274 (2.25) | 2991 (2.70) | 3388 (2.86) | <0.001 |
Endocrine hypertension [n (%)] | 5276 (7.25) | 6823 (6.76) | 8147 (7.36) | 9757 (8.25) | <0.001 |
Cushing's syndrome [n (%)] | 771 (1.06) | 995 (0.98) | 1172 (1.05) | 1349 (1.14) | 0.012 |
Primary aldosteronism [n (%)] | 3991 (5.49) | 5148 (5.10) | 6293 (5.68) | 7564 (6.40) | <0.001 |
Pheochromocytoma [n (%)] | 444 (0.61) | 660 (0.65) | 659 (0.59) | 790 (0.66) | 0.313 |
Diseases of aorta [n (%)] | 739 (1.01) | 1124 (1.11) | 1401 (1.26) | 1798 (1.52) | <0.001 |
Obstructive sleep apnea syndrome [n (%)] | 17 732 (24.39) | 25 835 (25.61) | 30 467 (27.52) | 35 421 (29.98) | <0.001 |